` Comparison: 206650 vs CANF - Alpha Spread

E
206650
vs
C
CANF

Over the past 12 months, EuBiologics Co Ltd has significantly outperformed CANF, delivering a return of +18% compared to the CANF's 88% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
206650
CANF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

E
Intrinsic Value
22 117.27 KRW
Undervaluation 39%
Intrinsic Value
Price
C
CANF Intrinsic Value
5 120.66 ILS
Undervaluation 86%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
E
EuBiologics Co Ltd
KOSDAQ:206650
13 460 KRW
C
Can Fite Biopharma Ltd
TASE:CANF
692 ILS
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
206650, CANF

206650
CANF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
E
EuBiologics Co Ltd
Revenue
C
Can Fite Biopharma Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
206650, CANF

206650
CANF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
E
EuBiologics Co Ltd
KOSDAQ:206650
C
Can Fite Biopharma Ltd
TASE:CANF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

EuBiologics Co Ltd
56.4%
CANF
0%

Operating Margin

EuBiologics Co Ltd
41.4%
CANF
-1 487.2%

Net Margin

EuBiologics Co Ltd
31.9%
CANF
-1 456.2%

FCF Margin

EuBiologics Co Ltd
41.5%
CANF
-953.8%

ROE

EuBiologics Co Ltd
35.1%
CANF
-382.9%

ROA

EuBiologics Co Ltd
24.6%
CANF
-187%

ROIC

EuBiologics Co Ltd
39.2%
CANF
-6 189.1%

ROCE

EuBiologics Co Ltd
38.9%
CANF
-273.3%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
206650, CANF

Loading
206650
CANF
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
206650, CANF

Loading
206650
CANF
Difference
www.alphaspread.com

Performance By Year
206650, CANF

Loading
206650
CANF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 206650 to other stocks
PNEXF
Pharnext SCA
ABBV
Abbvie Inc
AMGN
Amgen Inc
GILD
Gilead Sciences Inc
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account